Professional Documents
Culture Documents
Diabetic Nephropathy PDF
Diabetic Nephropathy PDF
Kidney Disease
SV Madhu
INTRODUCTION
Medicine Update-2011
157
158
Medicine Update-2011
Table I. Recommendations for the use of oral anti-diabetic agents in patients with diabetes and renal disease
Medicine Update-2011
REFERENCES
1.
The Diabetes Control and Complications Trial Research Group. The
effect of intensive treatment of diabetes on the development and
progression of long-term complications in insulin-dependent diabetes
mellitus. N Engl J Med 1993; 329: 977-986.
2.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood
glucose control with sulphonylureas or insulin compared with
conventional treatment and risk of complications in patients with
type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy
prevents the progression of diabetic microvascular complications in
Japanese patients with non-insulin-dependent diabetes mellitus: a
randomized prospective 6-year study. Diabetes Res Clin Pract 1995;
28: 103-117
4.
Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose
control and vascular outcomes in patients with type 2 diabetes. N
Engl J Med 2008; 358: 2560-2572
5.
Inoue T, Shibahara N, Miyagawa K et al. Pharmacokinetics of
nateglinide and its metabolites in subjects with type 2 diabetes
mellitus and renal failure. Clin Nephrol 2003; 60 :90-95
6.
Nagai T, Imamura M, Iizuka K, et al. Hypoglycemia due to nateglinide
in diabetic patient with chronic renal failure. Diabetes Res Clin Pract
2003; 59: 191-194
7.
Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs
affecting blood glucose in diabetic patients with renal failure.
8.
9.
10.
11.
12.
13.
14.
15.
159